Exact Sciences Corporation (EXAS)
| Chiusura precedente | 42,71 |
| Aperto | 42,64 |
| Denaro | 43,90 x 800 |
| Lettera | 43,90 x 900 |
| Min-Max giorno | 42,52 - 44,01 |
| Intervallo di 52 settimane | 35,34 - 108,99 |
| Volume | |
| Media Volume | 2.115.341 |
| Capitalizzazione | 7,77B |
| Beta (5 anni mensile) | 1,32 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -4,32 |
| Prossima data utili | 31 ott 2022 - 04 nov 2022 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 71,63 |
- GlobeNewswire
Diversey Appoints Katherine S. Zanotti to its Board of Directors
FORT MILL, S.C., March 01, 2022 (GLOBE NEWSWIRE) -- Diversey Holdings, Ltd. (NASDAQ: DSEY), a leading provider of hygiene, infection prevention and cleaning solutions, has appointed Katherine S. Zanotti to the company’s board of directors, effective March 1, 2022. This appointment will bring the total number of directors to eleven. “We are delighted to welcome Katherine (‘Kay’) to our board. Kay’s long history of leadership coupled with her extensive experience in sales and marketing within the
- GlobeNewswire
Renalytix Appoints Daniel J. Levangie to its Board of Directors
Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and HologicNEW YORK and SALT LAKE CITY, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) today announced the appointment of Daniel J. Levangie to the Company’s board of directors. Mr. Levangie is also appointed as a member of the Company’s remuneration committee. Mr. Levangie is an experienced executive and long-serving board director in the di
